Allianz Asset Management
MRNA icon

Allianz Asset Management’s Moderna MRNA Stock Holding History

Allianz Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,700
Closed -$473K – 2198
2025
Q1 		$473K Hold
16,700
– – ﹤0.01% 1895
2024
Q4 		$694K Hold
16,700
– – ﹤0.01% 1755
2024
Q3 		$1.12M Sell
16,700
-5,300
-24% -$487K ﹤0.01% 1609
2024
Q2 		$2.61M Buy
22,000
+21,700
+7,233% +$2.75M ﹤0.01% 1218
2024
Q1 		$32K Sell
300
-1,000
-77% -$101K ﹤0.01% 2010
2023
Q4 		$129K Sell
1,300
-5,700
-81% -$479K ﹤0.01% 2074
2023
Q3 		$723K Sell
7,000
-9,900
-59% -$1.1M ﹤0.01% 1804
2023
Q2 		$2.05M Sell
16,900
-900
-5% -$120K ﹤0.01% 1268
2023
Q1 		$2.73M Buy
17,800
+2,600
+17% +$429K ﹤0.01% 1245
2022
Q4 		$2.73M Buy
15,200
+14,300
+1,589% +$2.34M 0.01% 1172
2022
Q3 		$106K Sell
900
-2,600
-74% -$395K ﹤0.01% 1677
2022
Q2 		$500K Sell
3,500
-18,200
-84% -$2.6M ﹤0.01% 1891
2022
Q1 		$3.74M Buy
21,700
+12,800
+144% +$2.15M ﹤0.01% 1334
2021
Q4 		$2.26M Sell
8,900
-15,700
-64% -$4.59M ﹤0.01% 1565
2021
Q3 		$9.47M Buy
+24,600
New +$9.07M 0.01% 1035

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management's MRNA Position: Q1 2026 in Review

Allianz Asset Management increased its Moderna (MRNA) stake by 5,455% in Q1 2026, buying an estimated $45.3M and bringing the position to 988,908 shares worth $50.2M. The position accounts for 0.05% of the portfolio, ranked #327.

Allianz Asset Management first reported a position in MRNA in Q3 2019 and has held it in 25 quarters since. The position peaked at $464M in Q2 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Allianz Asset Management held 988,908 shares of Moderna worth $50.2M as of Q1 2026.
  • Allianz Asset Management bought 971,107 Moderna shares in Q1 2026, an estimated $45.3M.
  • Moderna made up 0.05% of Allianz Asset Management's portfolio in Q1 2026, its #327 holding.
  • Allianz Asset Management first reported a position in Moderna in Q3 2019 and has held it in 25 quarters since.
  • Allianz Asset Management's Moderna position peaked at $464M in Q2 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.